-Advertisement-
-Advertisement-
Trending Topics

Dupilumab linked to increased risk of ocular surface diseases
Dupilumab use is associated with an increased risk of developing or exacerbating ocular surface diseases (OSD), particularly dry eye, according to a study. Using the FDA Adverse Event Reporting System (FAERS) database, the study identified 85 signals of DIOSD between 2017 and 2023. Dry eye was the most frequently reported...
Read More-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Videos
16 Dec, 2024
Optometry 360 Editorial Advisory Board member Mary Beth Yackey, OD,...
-Advertisement-
-Advertisement-

Contact Info
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
© 2025 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved